Impact of Gram-positive resistance on outcome of nosocomial pneumonia

Critical Care Medicine

Volumn 29, Issue 4 SUPPL., 2001, Pages

  Bodi, M ^a   Ardanuy, C ^a   Rello, J ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Dalfopristin quinupristin; Gram positive; Linezolid; Methicillin resistant Staphylococcus aureus; Outcome; Pneumonia; Staphylococcus aureus; Treatment; Vancomycin; Ventilator associated pneumonia

Indexed keywords

6 (1 HYDROXYETHYL) 4 METHYL 3 [5 (4 METHYLAMINOMETHYLPHENYL) 3 PYRROLIDINYLTHIO] 7 OXO 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID; BETA LACTAM ANTIBIOTIC; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; EVERNINOMICIN; GLYCOPEPTIDE; KETOLIDE; L 786392; LINEZOLID; METICILLIN; ORITAVANCIN; OXAZOLIDINONE DERIVATIVE; STREPTOGRAMIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TISSUE LEVEL; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEPHROTOXICITY; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; SURVIVAL; TREATMENT OUTCOME;

EID: 0035046284     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200104001-00005     Document Type: Review

References (36)

1. Incidence, etiology and outcome of nosocomial pneumonia in mechanically ventilated patients
2. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes
3. Variations in etiology of ventilator-associated pneumonia across four treatment sites. Implications for antimicrobial prescribing practices
4. Appropriate antibiotic treatment for pneumonia
5. Molecular mechanisms of methicillin resistance in Staphylococcus aureus
6. Spread and maintenance of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone during an outbreak of MRSA disease in a Spanish hospital
7. Vancomycin resistance in Staphylococci
8. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
9. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
10. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin
11. Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital
12. A comparative analysis of patients with earlyonset vs late-onset nosocomial pneumonia in the ICU setting
13. Methicillin-resistant Staphylococcus aureus: Introduction and spread within a hospital
14. Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci
15. What's in a name? Is methicillin-resistant Staphylococcus aureus just another S. aureus when treated with vancomycin?
16. Mortality as an outcome in hospital-acquired pneumonia
17. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
18. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients
19. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms
20. Therapy of ventilator-associated pneumonia: "The Tarragona Strategy."
21. Centers for Disease Control: Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)
22. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance
23. Structure, biochemistry and mechanism of action of glycopeptide antibiotics
24. Changes in vancomycin pharmacokinetics in critically ill infants
25. Changes in vancomycin pharmacokinetics during treatment
26. Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates
27. Dose ranging randomized multicenter open phase II study of quinupristin/dalfopristin versus vancomycin in treatment of catheter-related Gram-positive bacteremia
28. Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia
29. Oxazolidinones: A review
30. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant Gram-positive bacterial infections
31. A novel antimicrobial agent joins the battle against resistant bacteria
32. Daptomycin: A novel agent for Gram-positive infections
33. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against Gram positive bacteria
34. Therapeutic efficacy of J-111,225, a novel trans-3,5-disubstituted pyrrolidinythio-1β-methylcarbapenem, against experimental murine systemic infections
35. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo
36. Activities of trovafloxacin and ampicillinsulbactam alone or in combination versus three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model